Lineage-negative human leukocyte antigen-DR+ cells with the phenotype of undifferentiated dendritic cells in patients with carcinoma of the abdomen and pelvis

Clinical Cancer Research

Volumn 4, Issue 3, 1998, Pages 799-809

  Melichar, Bohuslav ^a   Savary, Cherylyn ^a   Kudelka, Andrzej P ^a   Verschraegen, Claire ^a   Kavanagh, John J ^a   Edwards, Creighton L ^a   Platsoucas, Chris D ^b   Freedman, Ralph S ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD86 ANTIGEN; GAMMA INTERFERON; GLYCOPROTEIN P 15095; HLA DR ANTIGEN; INTERLEUKIN 10; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 3; TUMOR NECROSIS FACTOR ALPHA;

ABDOMINAL CANCER; ADULT; AGED; ANTIGEN PRESENTING CELL; ARTICLE; ASCITES; CARCINOMATOUS PERITONITIS; CELL LINE; CLINICAL ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; FLOW CYTOMETRY; GYNECOLOGIC CANCER; HLA SYSTEM; HUMAN; HUMAN CELL; MACROPHAGE ACTIVATION; PELVIS CANCER; PHENOTYPE; PRIORITY JOURNAL;

ABDOMINAL NEOPLASMS; ADULT; AGED; ANTIGENS, CD; ASCITES; DENDRITIC CELLS; FEMALE; FLOW CYTOMETRY; HLA-DR ANTIGENS; HUMANS; IMMUNOPHENOTYPING; IRRIGATION; MIDDLE AGED; OVARIAN NEOPLASMS; PELVIC NEOPLASMS; PERITONEAL NEOPLASMS; REFERENCE VALUES;

EID: 0031900886     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Willemse, P. H. B., De Vries, E. G. E., Mulder, N. H., Aalders, J. G., Bouma, J., and Sleijfer, D. T. Intraperitoneal human recombinant interferon α-2b in minimum residual ovarian cancer. Eur. J. Cancer, 26: 353-358, 1990.
2. Pujade-Lauraine, E., Guastella, J. P., Colombo, N., Devillier, P., Francois, E., Fumoleau, P., Monnier, A., Nooy, M., Mignot, L., Bugat, R., Marques, C., Mousseau, M., Netter, G., Maloisel, F., Larbaoui, S., and Brandely, M. Intraperitoneal recombinant interferon-γ in ovarian cancer patients with residual disease at second-look laparotomy. J. Clin. Oncol., 14: 343-350, 1996.
3. Freedman, R. S., Gibbons, J. A., Giedlin, M., Kudelka, A. P., Kavanagh, J. J., Edwards, C. L., Nash, M. A., and Platsoucas, C. D. Immunopharmacology and cytokine production of a low dose schedule of intraperitoneal administered human recombinant interleukin-2 in patients with advanced epithelial ovarian carcinoma. J. Immunother., 19: 443-451, 1997.
4. Steis, R. G., Urba, W. J., VanderMolen, L. A., Bookman, M. A., Smith, J. W., Clark, J. W., Miller, R. L., Crum, E. D., Beckner, S. K., and McKnight, J. E. Intraperitoneal lymphokine-activated killer cell and interleukin-2 therapy for malignancies limited to the peritoneal cavity. J. Clin. Oncol., 8: 1618-1629, 1990.
5. Freedman, R. S., Edwards, C. L., Kavanagh, J. J., Kudelka, A. P., Katz, R. L., Carrasco, C. H., Atkinson, E. N., Scott, W., Tomasovic, B., Templin, S., and Platsoucas, C. D. Intraperitoneal adoptive immunotherapy of ovarian carcinoma with tumor-infiltrating lymphocytes and low dose recombinant interleukin-2: a pilot trial. J. Immunother., 16: 198-210, 1994.
6. Freedman, R. S., Lenzi, R., Kudelka, A. P., Rosenblum, M., and Platsoucas, C. D. Intraperitoneal immunotherapy of peritoneal carcinomatosis. Cytokines Cell. Mol. Ther., in press, 1998.
7. Marrack, P., and Kappler, J. The T cell receptor. Science (Washington DC), 238: 1073-1079, 1987.
8. Geppert, T. D., Davis, L. S., Gur, H., Wacholtz, M. D., and Lipsky, P. E. Accessory cell signals involved in T-cell activation. Immunol. Rev., 117: 5-66, 1990.
9. Singer, K. H. Interactions between epithelial cells and T-lymphocytes: role of adhesion molecules. J. Leuk. Biol., 48: 367-374, 1990.
10. June, C. H., Bluestone, J. A., Nadles, L. M., and Thompson, C. B. The B7 and CD28 receptor families. Immunol. Today, 15: 321-331, 1994.
11. Linsley, P. S., and Ledbetter, J. A. The role of the CD28 receptor during T cell responses to antigen. Annu. Rev. Immunol., 11: 191-212, 1993.
12. Hersey, P., Si, Z., Smith, M. J., and Thomas, W. D. Expression of the costimulatory molecule B7 on melanoma cells. Int. J. Cancer, 58: 527-532, 1994.
13. Vánky, F., Hising, C., Sjöwall, K., Larsson, B., and Klein, E. Interferon-γ and tumor necrosis factor-α treatment of ex vivo human carcinoma cells potentiates their interaction with allogeneic lymphocytes. J. Interferon Cytokine Res., 16: 201-207, 1996.
14. Kooi, S., Zhang, H-Z., Patenia, R., Edwards, C. L., Platsoucas, C. D., and Freedman, R. S. HLA class I expression on human ovarian carcinoma cells correlates with T-cell infiltration in vivo and T-cell expansion in vitro in low concentrations of recombinant interleukin-2. Cell. Immunol., 174: 116-128, 1996.
15. Azuma, M., Yssel, H., Phillips, J. H., Spits, H., and Lanier, L. L. Functional expression of B7/BB1 on activated T lymphocytes. J. Exp. Med., 177: 845-850, 1993.
16. Lenschow, D. J., Walunas, T. L., and Bluestone, J. A. CD28/B7 system of T cell costimulation. Annu. Rev. Immunol., 14: 233-258, 1996.
17. Young, J. W., Koulova, L., Soergel, S. A., Clark, E. A., Steinman, R. M., and Dupont, B, The B7/BB1 antigen provides one of several costimulatory signals for the activation of CD4+ T lymphocytes by human blood dendritic cells in vitro. J. Clin. Invest., 90: 229-237, 1992.
18. Betjes, M. G. H., Tuk, C. W., Struijk, D. G., Krediet, R. T., Arisz, L., and Beelen, R. H. J. Antigen-presenting capacity of macrophages and dendritic cells in the peritoneal cavity of patients treated with peritoneal dialysis. Clin, Exp. Immunol., 94: 377-384, 1993.
19. Thomas, R., Davis, L. S., and Lipsky, P. E. Comparative accessory cell function of human peripheral blood dendritic cells and monocytes. J. lmmunol., 151: 6840-6851, 1993.
20. Ridge, J. P., Fuchs, E. J., and Matzinger, P. Neonatal tolerance revisited: turning on newborn T cells with dendritic cells. Science (Washington DC), 271: 1723-1727, 1996.
21. Celluzzi, C. M., Mayordomo, J. I., Storkus, W. J., Lotze, M. T., and Falo, L. D. J. Peptide-pulsed dendritic cells induce antigen-specific, CTL-mediated protective tumor immunity. J. Exp. Med., 183: 283-287, 1996.
22. Gabrilovich, D., Ciernik, F., and Carbone, D. P. Dendritic cells in antitumor immune responses. Cell. Immunol., 170: 101-110, 1996.
23. Gabrilovich, D., Nadaf, S., Corak, J., Berzofsky, J. A., and Carbone, D. P. II. Dendritic cells in antitumor responses. Cell. Immunol., 170: 111-119, 1996.
24. Hsu, F. J., Benike, C., Fagnoni, F., Liles, T. M., Czerwinski, D., Taidi, B., Engleman, E. G., and Levy, R. Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells. Nat. Med., 2: 52-58, 1996.
25. Zitvogel, L., Mayordomo, J. I., Tjandrawan, T., DeLeo, A. B., Clarke, M. R., Lotze, M. T., and Storkus, W. J. Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell associated cytokines. J. Exp. Med., 183: 87-97, 1996.
26. Peters, J. J., Gieseler, R., Thiele, B., and Steinbach, F. Dendritic cells: from oncogenetic orphans to myelomonocytic descendants. Immunol. Today., 17: 273-278, 1996.
27. Steinman, R. M. The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol., 9: 271-296, 1991.
28. O'Doherty, U., Peng, M., Gezelter, S., Swiggard, J., Betjes, M., Bhardwaj, N., and Steinman, R. M. Human blood contains two subsets of dendritic cells, one immunologically mature and the other immature. Immunology 82: 487-493, 1994.
29. Ferbas, J. J., Toso, J. F., Logar, A. J., Navratil, J. S., and Rinaldo, C. R. J. CD4+ blood dendritic cells are potent producers of IFN-α in response to in vitro HIV-1 infection. J. Immunol., 152: 4649-4662, 1994.
30. Buelens, C., Willems, F., Delvaux, A., Piérard, G., Delville, J-P., Velu, T., and Goldman, M. Interleukin-10 differentially regulates B7-1 (CD80) and B7-2 (CD86) expression on human peripheral blood dendritic cells. Eur. J. Immunol., 25: 2668-2672, 1995.
31. Everson, M. P., McDuffie, D. S., Lemak, D. G., Koopman, W. J., McGhee, J. R., and Beagley, K. W. Dendritic cells from different tissues induce production of different T cell cytokine profiles. J. Leuk. Biol., 59: 494-498, 1996.
32. Mitra, R. S., Judge, T. A., Nestle, F. O., Turka, L. A., and Nickoloff, B. J. Psoriatic skin-derived dendritic cell function is inhibited by exogenous IL-10. J. Immunol., 154: 2668-2677, 1995.
33. O'Doherty, U., Steinman, R. M., Peng, M., Cameron, P. U., Gezelter, S., Kopeloff, I., Swiggard, W. J., Pope, M., and Bhardwaj, N. Dendritic cells freshly isolated from human blood express CD4 and mature into typical immunostimulatory dendritic cells after culture in monocyte-conditioned medium. J. Exp. Med., 178: 1067-1078, 1993.
34. Abuzakouk, M., Feighery, C., and O'Farrefly, C. Collagenase and dispase enzymes disrupt lymphocyte surface molecules. J. Immunol. Methods, 194: 211-216, 1996.
35. Kubicka, U., Olszewski, W. L., Tarnowski, W., Bielecki, K., Ziolkowska, A., and Wierzbicki, Z. Normal human immune peritoneal cells: subpopulations and functional characteristics. Scand. J. Immunol., 44: 150-156, 1985.
36. Inoue, K., Furihata, M., Ohtsuki, Y., and Fujita, Y. Distribution of S-IOO protein-positive dendritic cells and expression of HLA-DR antigen in transitional cell carcinoma of the urinary bladder in relation to tumour progression and prognosis. Virchows Arch. A Pathol. Anat. Histopathol., 422: 351-355, 1993.
37. Furihata, M., Ohtsuki, Y., Iwata, J., Sonobe, H., Araki, K., Ogoshi, S., and Ohmori, K. HLA-DR antigen- and S-100 protein-positive dendritic cells in esophageal squamous cell carcinoma: their distribution in relation to prognosis. Virchows Arch. B Cell Pathol. Incl. Mol. Pathol., 61: 409-414, 1992.
38. Melichar, B., Jandik, P., Krejsek, J., Solichova, D., Drahosova, M., Skopec, F., Mergancova, J., and Voboril, Z. Mitogen-induced lymphocyte proliferation and systemic immune activation in cancer patients. Tumori, 82: 218-220, 1996.
39. Reibnegger, G. J., Bichler, A. H., Dapunt, O., Fuchs, D. N., Fuith, L. C., Hausen, A., Hetzel, H. M., Lutz, H., Werner, E., and Wachter, H. Neopterin as a prognostic indicator in patients with carcinoma of the uterine cervix. Cancer Res., 46: 950-955, 1986.
40. Weiss, G., Krongerger, P., Conrad, F., Bodner, E., Wachter, H., and Reibnegger, G. Neopterin and prognosis in patients with adenocarcinoma of the colon. Cancer Res., 53: 260-265, 1993.
41. Cella, M., Scheidegger, D., Palmer-Lehmann, K., Lane, P., Lanzavecchia, A., and Albert, G. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J. Exp. Med., 184: 747-752, 1996.
42. Zitvogel, L., Couderc, B., Mayordomo, J. I., Robbins, P. D., Lotze, M. T., and Storkus, W. J. IL-12 engineered dendritic cells serve as effective tumor vaccine adjuvants in vivo. Ann. NY Acad. Sci., 795: 284-293, 1996.
43. Krummel, M. F., and Allison, J. P. CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation. J. Exp. Med., 182: 459-465, 1995.
44. Freedman, R. S., Edwards, C. L., Bowen, J. M., Tomasovic, B., Patenia, R., and Scott, W. Regional clinical responses following intraperitoneal injection of allogeneic viral oncolysate in patients with epithelial ovarian carcinoma. In: G. Basten, D. Wallwiener, and I. Keckstein (eds.), 2nd European Congress in Gynaecological Endoscopy and New Surgical Techniques, pp. 35-42. Bologna, Italy: Monduzzi Editore, 1993.